MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, R.-X.
Right arrow Articles by Limbird, L. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, R.-X.
Right arrow Articles by Limbird, L. E.

Vol. 52, Issue 6, 1071-1080, 1997

Distribution of mRNA Encoding Three alpha 2-Adrenergic Receptor Subtypes in the Developing Mouse Embryo Suggests a Role for the alpha 2A Subtype in Apoptosis

Ren-Xue Wang1 and Lee E. Limbird

Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232

alpha 2-Adrenergic receptors (alpha 2-ARs) respond to norepinephrine and epinephrine to mediate diverse physiological effects. Using in situ hybridization, the expression pattern of the mRNA encoding the three alpha 2-AR subtypes (alpha 2A, alpha 2B, and alpha 2C) was examined in the mouse embryo. The mRNA encoding the three subtypes was first detected at stage 9.5 days postcoitus (d.p.c.) for the alpha 2A-AR (coincident with norepinephrine availability), 11.5 d.p.c. for the alpha 2B-AR, and 14.5 d.p.c. for the alpha 2C-AR subtype. The mRNA encoding the alpha 2A-AR subtype shows both the earliest and the most widespread expression pattern, including developing stomach and cecum, many craniofacial regions and areas in the central nervous system. Strikingly, the alpha 2A-AR mRNA is expressed in the interdigital mesenchyme between stage 12.5 and 14.5 d.p.c. in parallel with digit separation, raising the possibility that the alpha 2A-AR might contribute to the apoptotic events underlying this process. To test whether alpha 2A-AR can signal apoptotic events, the alpha 2A-AR subtype was introduced into two mouse mesenchymal cell lines, C3H/10t1/2 and NIH-3T3; expression of the alpha 2A-AR correlated with accelerated apoptosis, as detected both by the TUNEL assay and the loss of cell viability. In contrast to the wide distribution of mRNA encoding the alpha 2A-AR subtype, the alpha 2B-AR mRNA was detected only in the developing liver and was most readily detectable between 11.5 and 14.5 d.p.c., when the liver is the principal site of hematopoiesis. The alpha 2C-AR mRNA is detected in the nasal cavity and cerebellar primordium only at >= 14.5 d.p.c. These studies represent the first characterization of the temporal and spatial expressions of the alpha 2A-AR, alpha 2B-AR, and alpha 2C-AR subtypes during embryogenesis and provide important insights concerning the loci and possible roles of alpha 2-AR-mediated regulation of physiological processes during the developmental program.


Copyright © 1997 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
ReproductionHome page
S. Cikos, P. Rehak, S. Czikkova, J. Vesela, and J. Koppel
Expression of adrenergic receptors in mouse preimplantation embryos and ovulated oocytes
Reproduction, June 1, 2007; 133(6): 1139 - 1147.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Debrus, L. Rahbani, M. Marttila, B. Delorme, P. Paradis, and M. Nemer
The Zinc Finger-Only Protein Zfp260 Is a Novel Cardiac Regulator and a Nuclear Effector of {alpha}1-Adrenergic Signaling
Mol. Cell. Biol., October 1, 2005; 25(19): 8669 - 8682.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
F B Kalapesi, M T Coroneo, and M A Hill
Human ganglion cells express the alpha-2 adrenergic receptor: relevance to neuroprotection
Br. J. Ophthalmol., June 1, 2005; 89(6): 758 - 763.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
R. J. KOLETSKY, R. A. VELLIQUETTE, and P. ERNSBERGER
The Role of I1-Imidazoline Receptors and a2-Adrenergic Receptors in the Modulation of Glucose and Lipid Metabolism in the SHROB Model of Metabolic Syndrome X
Ann. N.Y. Acad. Sci., December 1, 2003; 1009(1): 251 - 261.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H. K. Happe, D. B. Bylund, and L. C. Murrin
Alpha-2 Adrenergic Receptor Functional Coupling to G Proteins in Rat Brain During Postnatal Development
J. Pharmacol. Exp. Ther., March 1, 1999; 288(3): 1134 - 1142.
[Abstract] [Full Text]


Home page
HypertensionHome page
F. A. Gesek
{alpha}1- and {alpha}2-Adrenoceptor Control of Sodium Transport Reverses in Developing Hypertension
Hypertension, January 1, 1999; 33(1): 524 - 529.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics